One year of qualification
Audited Supplier
In This Store
Yantai Zhaoyi Biochnology Co., Ltd. is located in Yantai City, Shandong Province, where the transportation is convenient, rich products, advantageous geographical location, obvious geographical advantages, waterways, aviation, railways, roads are very convenient. The company is a high-tech enterprise integrating science, industry and trade, jointly established in 2017 by Suzhou Wangshan Wangshui Co., LTD., Shanghai Institute of Pharmaceutical Chemistry of Chinese Academy of Sciences, Professor Zhang Hua and Professor Zhang Guangyou, National Outstanding youth in natural science, Ludong University and Jinan University. The company focuses on nutritional supplements, natural product concentrates, API and other high-end products for human health life, and is committed to the development and research of pharmacological applications and health applications of natural products with great market potential in the big health industry, and to realize industrialization and marketization. The company has a perfect R & D platform, test platform. In strict accordance with ISO9001, ISO22000, FDA, CFDA, GMP, KOSHER, HALAL and other international quality management system standards management, product quality in line with international requirements. Adhering to the core values of "integrity, openness, innovation, win-win", the company sincerely develops cooperation with international and domestic customers, and will provide better services for international and domestic customers with sincere enthusiasm.
Year of Establishment: 2017
Total Assets(USD):
Total Number of Staff: 50-100
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight January 2025
